Recent Patents on Drug Delivery & Formulation
Title: Patent Selections
Volume: 2 Issue: 2
Author(s): Bentham Science Publishers
Affiliation:
Export Options
About this article
Cite this article as:
Bentham Science Publishers , Patent Selections, Recent Patents on Drug Delivery & Formulation 2008; 2 (2) . https://dx.doi.org/10.2174/187221108784534090
DOI https://dx.doi.org/10.2174/187221108784534090 |
Print ISSN 1872-2113 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4039 |
12
Related Articles
-
Emerging Features in the Regulation of MMP-9 Gene Expression for the Development of Novel Molecular Targets and Therapeutic Strategies
Current Drug Targets - Inflammation & Allergy Neuroprotective Effects of Exercise Treatments After Injury: The Dual Role of Neurotrophic Factors
Current Neuropharmacology Dendrimer Based Nanoarchitectures in Diabetes Management: An Overview
Current Pharmaceutical Design Exercise Addiction- Diagnosis, Bio-Psychological Mechanisms and Treatment Issues
Current Pharmaceutical Design Topical Ingenol Mebutate: A New Treatment Modality for Multiple Actinic Keratoses and Field Cancerization
Anti-Cancer Agents in Medicinal Chemistry A Computational View of COX-2 Inhibition
Anti-Cancer Agents in Medicinal Chemistry Potential Therapeutic Effects of Exercise to the Brain
Current Medicinal Chemistry Hydroximic Acid Derivatives: Pleiotropic Hsp Co-Inducers Restoring Homeostasis and Robustness
Current Pharmaceutical Design Blood Pressure Variability/Dipper/Non-dipper in Hypertension and Diabetes
Current Hypertension Reviews Editorial from Editor-in-Chief (Wedding Bells: Animal Venoms and Therapeutic Drug Candidates)
Inflammation & Allergy - Drug Targets (Discontinued) New Insights into Adipokines as Potential Biomarkers for Type-2 Diabetes Mellitus
Current Medicinal Chemistry Drosophila melanogaster As a Model Host for the Study of Microbial Pathogenicity And the Discovery of Novel Antimicrobial Compounds
Current Pharmaceutical Design Circumventing Immune Tolerance Through Epigenetic Modification
Current Pharmaceutical Design The Use of Nitric Oxide Synthase Inhibitors in Inflammatory Diseases: A Novel Class of Anti-Inflammatory Agents
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Systemic Inflammation, Infection, ApoE Alleles, and Alzheimer Disease: A Position Paper
Current Alzheimer Research Targeting B Cells in SLE: The Experience with Rituximab Treatment (Anti-CD20)
Endocrine, Metabolic & Immune Disorders - Drug Targets Diversity-Oriented Synthetic Approaches for Furoindoline: A Review
Current Organic Synthesis The Impact of Human Allelic Variation on HIV-1 Disease
Current HIV Research In Silico Prediction of Hepatotoxicity
Current Computer-Aided Drug Design Re-evaluation of Fibrogenic Cytokines in Lung Fibrosis
Current Pharmaceutical Design